Food and Drug Administration (FDA) added Ozempic and Wegovy to its Drug Shortages List
Unlike older weight loss drugs that target a single hormone pathway, retatrutide activates three separate receptors: GLP-1 (glucagon like peptide 1), which slows digestion and reduces appetite GIP (glucose dependent insulinotropic polypeptide), which helps regulate blood sugar and insulin release Glucagon, which increases energy expenditure and supports fat burning By working on all three pathways together, retatrutide aims to produce a stronger combined effect than medicines that only target one or two of these hormones, such as semaglutide or tirzepatide
If you experience constipation, adding more fiber to your diet and staying active can help improve digestion
FADD, Fas Associated Via Death Domain
doi: 10.1186/s13059-014-0550-8 58 MaM.JiangW.ZhouR
We have unimolecular, dual agonist, tri-agonist, [and] tetra-agonists, where you can just add an alkyl group, and then you can tune GLP-1 receptor [sensitivity] up or down, says Kumar